How has been the historical performance of Max Healthcare?

Answer:Max Healthcare has shown significant growth in its historical performance, particularly in net sales and profitability over the past few years. For the fiscal year ending March 2025, net sales reached 7,028.46 crore, a substantial increase from 5,406.02 crore in March 2024 and 4,562.60 crore in March 2023. The total operating income mirrored this upward trend, rising to 7,028.46 crore in March 2025 from 5,406.02 crore in the previous year. Operating profit (PBDIT) also saw a notable increase, reaching 2,004.44 crore in March 2025, compared to 1,670.19 crore in March 2024. Profit before tax was reported at 1,406.37 crore, slightly up from 1,365.32 crore in March 2024, while profit after tax was 1,075.88 crore, reflecting a consistent performance over the years.

In terms of assets and liabilities, total assets grew to 15,186.44 crore in March 2025 from 11,999.94 crore in March 2024, indicating a strong expansion strategy. Total liabilities also increased, reaching 15,186.44 crore in March 2025, up from 11,999.94 crore in March 2024. The cash flow from operating activities improved to 1,459.00 crore in March 2025, compared to 1,121.00 crore in March 2024, although cash flow from investing activities showed a negative trend at -1,614.00 crore. The closing cash and cash equivalents stood at 661.00 crore in March 2025, down from 979.00 crore in March 2024, indicating a need for careful cash management despite the overall growth in sales and profits.

Breakdown:
Max Healthcare's financial trajectory illustrates robust growth, with net sales escalating from 1,059.03 crore in March 2020 to 7,028.46 crore in March 2025. This growth is complemented by a rise in total operating income, which has consistently increased over the years. The operating profit margin, although slightly decreased to 26.3% in March 2025 from 27.6% in March 2024, still reflects strong operational efficiency. Profit before tax has shown resilience, increasing to 1,406.37 crore in March 2025, while profit after tax remained stable at 1,075.88 crore. On the balance sheet, total assets have surged, indicating significant investment and expansion, while total liabilities have also risen, reflecting the company's growing financial obligations. Cash flow from operating activities has improved, showcasing effective cash generation, although the negative cash flow from investing activities suggests ongoing capital expenditures. Overall, Max Healthcare's financial performance indicates a solid growth trajectory with a focus on expanding its operational capabilities.